Moderna shares have increased significantly, with some reports indicating the stock has more than doubled this year. The surge may be driven by anticipation of upcoming updates, although the exact reason for the increase is unclear. The stock's performance is outpacing overall market gains, with reports of a 6.3% and 7.5% surge, suggesting potential for further gains.